Neurocrine Biosciences Presents New Two-Year Data From Phase 3 CAHtalyst Pediatric Trial Of CRENESSITY At Endocrine Society's Annual Meeting

뉴스 본문을 불러오고 있어요.

Neurocrine Biosciences Presents New Two-Year Data From Phase 3 CAHtalyst Pediatric Trial Of CRENESSITY At Endocrine Society's Annual Meeting | 웨이프 WAPE

Neurocrine Biosciences Presents New Two-Year Data From Phase 3 CAHtalyst Pediatric Trial Of CRENESSITY At Endocrine Society's Annual Meeting

기사 요약

관련 종목

댓글 —